Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea flag South Korea · Delayed Price · Currency is KRW
149,600
-2,300 (-1.51%)
At close: Apr 29, 2026

Daewoong Pharmaceutical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
168,942102,950111,506102,95175,907
Upgrade
Short-Term Investments
3,8605,0773,00010,00097,827
Upgrade
Trading Asset Securities
-8,32023,17927,700-
Upgrade
Cash & Short-Term Investments
172,801116,347137,685140,651173,734
Upgrade
Cash Growth
48.52%-15.50%-2.11%-19.04%-1.91%
Upgrade
Accounts Receivable
166,724160,742137,506142,165121,591
Upgrade
Other Receivables
48,33651,15040,38636,97936,916
Upgrade
Receivables
215,161211,894177,892179,144159,508
Upgrade
Inventory
310,876256,353241,545208,736170,559
Upgrade
Prepaid Expenses
17,89615,9508,5347,5986,604
Upgrade
Other Current Assets
15,62412,2489,16812,8409,996
Upgrade
Total Current Assets
732,358612,792574,824548,968520,401
Upgrade
Property, Plant & Equipment
842,341675,666521,919440,890395,866
Upgrade
Long-Term Investments
250,179180,703203,792146,335118,369
Upgrade
Goodwill
60,84860,84860,84860,84860,848
Upgrade
Other Intangible Assets
78,10683,06980,00184,62081,406
Upgrade
Long-Term Accounts Receivable
----569.7
Upgrade
Long-Term Deferred Tax Assets
78,58068,78671,30464,13658,565
Upgrade
Long-Term Deferred Charges
228,570202,793156,636120,54082,915
Upgrade
Other Long-Term Assets
88,47588,61397,66093,74591,747
Upgrade
Total Assets
2,362,7991,976,9771,770,3111,563,3411,410,687
Upgrade
Accounts Payable
106,23483,043101,09983,40170,852
Upgrade
Accrued Expenses
24,96324,01024,08520,63515,485
Upgrade
Short-Term Debt
70,829206,495167,426141,74256,109
Upgrade
Current Portion of Long-Term Debt
205,947115,000204,94391,931199,878
Upgrade
Current Portion of Leases
1,1712,0021,9611,183987.32
Upgrade
Current Income Taxes Payable
11,5458,14614,4974,9064,734
Upgrade
Current Unearned Revenue
14.8476.1559.2230.67-
Upgrade
Other Current Liabilities
168,120155,573153,047129,004112,615
Upgrade
Total Current Liabilities
588,823594,346667,117472,831460,660
Upgrade
Long-Term Debt
550,561324,47865,000204,840181,713
Upgrade
Long-Term Leases
882.621,2741,9417,0157,008
Upgrade
Pension & Post-Retirement Benefits
-722.46---
Upgrade
Long-Term Deferred Tax Liabilities
1,6153,5305,0094,0533,580
Upgrade
Other Long-Term Liabilities
86,26290,57390,547133,37859,811
Upgrade
Total Liabilities
1,228,1441,014,923829,614822,118712,772
Upgrade
Common Stock
28,96628,96628,96628,96628,966
Upgrade
Additional Paid-In Capital
149,816149,892149,175121,582123,649
Upgrade
Retained Earnings
833,595635,674618,864504,294467,361
Upgrade
Treasury Stock
-2,850-2,850-2,850-18,360-18,360
Upgrade
Comprehensive Income & Other
-3,435-17,044-26,852-28,466-32,085
Upgrade
Total Common Equity
1,006,093794,640767,303608,017569,531
Upgrade
Minority Interest
128,562132,345144,978133,206128,384
Upgrade
Shareholders' Equity
1,134,656962,055940,696741,223697,915
Upgrade
Total Liabilities & Equity
2,362,7991,976,9771,770,3111,563,3411,410,687
Upgrade
Total Debt
829,390649,249441,270446,711445,695
Upgrade
Net Cash (Debt)
-656,589-532,902-303,585-306,060-271,961
Upgrade
Net Cash Per Share
-57063.54-46314.03-26572.35-27649.69-24713.54
Upgrade
Filing Date Shares Outstanding
11.5111.5111.5111.0711.07
Upgrade
Total Common Shares Outstanding
11.5111.5111.5111.0711.07
Upgrade
Working Capital
143,53518,447-92,29376,13759,742
Upgrade
Book Value Per Share
87438.7069061.4666685.6654928.7251451.87
Upgrade
Tangible Book Value
867,140650,723626,454462,550427,278
Upgrade
Tangible Book Value Per Share
75362.3656553.7454444.6041787.0538600.56
Upgrade
Land
89,21283,84097,59894,45969,482
Upgrade
Buildings
316,093296,280267,669261,085247,556
Upgrade
Machinery
379,247360,301340,864325,145307,618
Upgrade
Construction In Progress
400,304267,131131,73158,32847,216
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.